BMP-7/TGF-β1 signalling in myoblasts: components involved in signalling and BMP-7-dependent blockage of

Steffen K Meurer1, Marcel Esser, Lidia Tihaa

  • 1The Institute of Clinical Chemistry and Pathobiochemistry, RWTH University Hospital, Pauwelsstr. 30, D-52074 Aachen, Germany. smeurer@ukaachen.de

Insights

Bone morphogenetic protein-7 (BMP-7) antagonizes TGF-β1 signaling by modulating Mitogen-activated protein kinases, not solely through Smad activation, impacting connective tissue growth factor (CTGF) expression.

Area of Science:

  • Cellular and Molecular Biology
  • Signal Transduction Pathways
  • Protein Interactions

Background:

  • Bone morphogenetic protein-7 (BMP-7) is known to antagonize transforming growth factor-beta (TGF-β) signaling and myogenic differentiation.
  • The precise molecular mechanisms underlying BMP-7's antagonistic role require further elucidation.

Purpose of the Study:

  • To investigate the specific mechanisms by which BMP-7 modulates TGF-β1 signaling.
  • To analyze the roles of individual signaling components in mediating TGF-β1 and BMP-7 responses.
  • To determine the impact of BMP-7 on connective tissue growth factor (CTGF) expression and its regulation.

Main Methods:

  • Analysis of gene and protein expression in response to TGF-β1 and BMP-7 stimulation.
  • Overexpression and knockdown studies using Smad and Id proteins, as well as ALK2/3 and Smad1/5.
  • Inhibition studies using SB431542 (ALK5 inhibitor) and ERK1/2 inhibitors.
  • Measurement of CTGF expression at various time points post-stimulation.

Main Results:

  • BMP-7 (25 ng/ml) exclusively activates ALK2/3, leading to Smad1/5 and Id protein activation.
  • Low-dose TGF-β1 (0.1 ng/ml) exclusively activates ALK5, phosphorylating Smad2/3 and inducing CTGF.
  • BMP-7 reduces TGF-β1-induced CTGF expression; Smad1/5 or Id1/2 overexpression partially reduces CTGF.
  • siRNA knockdown of ALK2/3 or Smad1/5 counteracts BMP-7's effect on basal CTGF but not TGF-β1-mediated CTGF.
  • ALK5 inhibition affects CTGF later; ERK1/2 inhibition abrogates CTGF expression.

Conclusions:

  • BMP-7's antagonistic role in TGF-β1 signaling is primarily mediated through the modulation of Mitogen-activated protein kinases (MAPKs).
  • Differential Smad activation alone does not fully explain BMP-7's regulatory effects on CTGF expression.
  • These findings highlight a complex interplay between BMP-7, TGF-β1, Smad, and MAPK pathways in regulating gene expression.